| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6503
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416 |
| filingDate |
2009-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63cbfbae981db9a83d4e0e0f7e15a7cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45dc8d1d9f2eacf9261209d374179004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69d5b7543d53e67c6f537941002ba0c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_234ae75edcdfed55b2c7c2e4857bd88c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19368948960ddeac036bb7ed8be65477 |
| publicationDate |
2010-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2010006825-A |
| titleOfInvention |
Ophthalmic composition for high intraocular pressure treatment |
| abstract |
Ophthalmic compositions for the treatment of intraocular pressure for the treatment of potent potassium channel blocker indazole derivatives or other conditions that lead to glaucoma and increased intraocular pressure in a patient's eye. The compounds listed in Table 1 below provide a neuroprotective action in the eyes of mammals, particularly humans. The treatment method of glaucoma and / or high intraocular pressure (intraocular pressure increase) using the novel imidazole compound shown by these. [Selection figure] None |
| priorityDate |
2002-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |